Phase IIa trial of oral exenatide capsules [ORMD 0901] for type 2 diabetes mellitus

Trial Profile

Phase IIa trial of oral exenatide capsules [ORMD 0901] for type 2 diabetes mellitus

Recruiting
Phase of Trial: Phase II

Latest Information Update: 03 Jun 2013

At a glance

  • Drugs Exenatide (Primary)
  • Indications Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Most Recent Events

    • 03 Jun 2013 Status changed from planning to recruiting, based on information in an Oramed Pharmaceuticals media release reporting that the trial is underway.
    • 05 Apr 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top